Antigen Discovery Company

ANTIGEN DISCOVERY, INC. AWARDED PHASE II SBIR GRANT TO IDENTIFY BIOMARKERS ASSOCIATED WITH PROTECTION AGAINST MALARIA

Investors

Technology: Immunological Biomarkers
Industry: Omics-based
Headquarters: Irvine, California, United States
Founded Date: 2004
Estimated Revenue: $10M to $50M
Visit Website
info@antigendiscovery.com
https://www.twitter.com/antigendiscover
Register and Claim Ownership